Benvenuti sul sito web di Farmacovigilanza

Feed rss AIFA: Notizia

29/04/2026

Attivazione web Registro di monitoraggio OPDIVO Carcinoma Uroteliale

Ultime notizie

26/03/2026

C’è un legame tra fatigue ed eventi avversi correlati alle terapie oncologiche?

Biblioteca Virtuale per la Salute – Piemonte

24/04/2026

Newsletter trimestrale Medicina di Genere – aprile 2026

Agendas and minutes

28/04/2026

Agenda - European Platform for Regulatory Science Research meeting

Consumer Updates RSS Feed

20/04/2026

Animal Welfare, Testing and Research of FDA-Regulated Products

Regulatory and procedural guidelines (human and veterinary)

29/04/2026

Pharmacovigilance-related regulatory recommendations for centrally authorised veterinary medicinal products during 2026

Scientific guidelines (human and veterinary)

24/04/2026

Draft concept paper on the development for guidance on demonstration of biosimilarity of biological veterinary medicinal products

Paediatric investigation plans

23/04/2026

Opinion/decision on a Paediatric investigation plan (PIP): Skyrizi, risankizumab, decision type: PM: decision on the application for modification of an agreed PIP, therapeutic area: Dermatology, PIP number: P/0497/2022

Orphan designations

24/04/2026

Orphan designation: diazoxide choline Treatment of Prader-Willi syndrome, 12/10/2017 Positive

New medicines and opinions: human

24/04/2026

Human medicines European public assessment report (EPAR): Cenrifki, tolebrutinib, Status: Opinion

MedWatch Safety Alerts RSS Feed

28/04/2026

Blood Glucose Monitor Recall: Trividia Health Issues Correction for TRUE METRIX Blood Glucose Monitoring Systems

What's New: Drugs RSS Feed

29/04/2026

Drug Trials Snapshots: ENFLONSIA

FDA Drug Safety Podcasts

02/01/2025

Serious liver injury being observed in patients without cirrhosis taking Ocaliva (obeticholic acid) to treat primary biliary cholangitis